Centinel Spine announced the completion of 7,500 U.S. cases with the prodisc C Vivo and prodisc C SK Cervical TDR System since the limited commercial launch two years ago, in September 2022. This is an increase from 5,000 cases reported in April 2024.
prodisc C Vivo and prodisc C SK technologies are part of Centinel Spine’s Match-the-Disc System. In two years, nearly 800 U.S. spine surgeons have used the new system. Nearly 75% of these are repeat users and a strong majority are competitive conversions.
Commemorating the 7,500th U.S. procedure with the prodisc C Vivo and prodisc C SK Cervical TDR System, Centinel Spine CEO Steve Murray notes, “While we are pleased to have gained market share in the cervical disc replacement market, we are particularly inspired by the clear trend toward motion preservation versus cervical spinal fusion. The Level I clinical evidence is clear: TDR is beneficial over fusion for many patients.”
Centinel Spine announced the completion of 7,500 U.S. cases with the prodisc C Vivo and prodisc C SK Cervical TDR System since the limited commercial launch two years ago, in September 2022. This is an increase from 5,000 cases reported in April 2024.
prodisc C Vivo and prodisc C SK technologies are part of Centinel Spine's Match-the-Disc...
Centinel Spine announced the completion of 7,500 U.S. cases with the prodisc C Vivo and prodisc C SK Cervical TDR System since the limited commercial launch two years ago, in September 2022. This is an increase from 5,000 cases reported in April 2024.
prodisc C Vivo and prodisc C SK technologies are part of Centinel Spine’s Match-the-Disc System. In two years, nearly 800 U.S. spine surgeons have used the new system. Nearly 75% of these are repeat users and a strong majority are competitive conversions.
Commemorating the 7,500th U.S. procedure with the prodisc C Vivo and prodisc C SK Cervical TDR System, Centinel Spine CEO Steve Murray notes, “While we are pleased to have gained market share in the cervical disc replacement market, we are particularly inspired by the clear trend toward motion preservation versus cervical spinal fusion. The Level I clinical evidence is clear: TDR is beneficial over fusion for many patients.”
Copy to clipboard 
